Lilly shares hit a record as weight-loss drugs became more accessible.

U.S. stocks saw a stronger reversal in fortunes in October, as worries about dwindling free cash flows and rising borrowing ...

As conditions stand today, Target stock could hit the bull's eye for investors.

Rocket Companies remains a buy after strong Q3 earnings, resilient profitability, and compelling valuation. Read more on RKT ...

Lilly is the maker of tirzepatide, a drug sold under the name Mounjaro for type 2 diabetes and as Zepbound for weight loss.

The e-commerce company has beaten its own forecast all year. Is a cheaper stock enough to buy ahead of the next one?

Canton Strategic's tokenized shares are set to trade as early as November 2. Learn what it would take for Canton Coin to ...

In their latest earnings release, BNP showed an increase in revenues of about 9.5% on a year-over-year basis from around ...

ExxonMobil just released its Q3 2026 scorecard and the share price reacted immediately. The stock closed at US$187.25, up 2.2 ...

Wall Street closed October with a brutal selloff, erasing roughly $2 trillion from the Nasdaq-100's market value as investors ...

The Financial Services Authority (OJK) has revealed a number of considerations that underlie Morgan Stanley Capital ...

Polling is looking grim for Republicans ahead of the U.S. midterm elections on Nov. 3, 2026, due in large part to deep ...